RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Anthracene-Modified Nanoporous Silica Nanoparticles for ATP Detection and Salivary Diagnostics in Parkinson&apos, s Disease
[EN] ATP is an essential biological molecule, and abnormal levels are linked to various diseases. In this study, we developed an optical sensor array consisting of an anthracene-modified MCM-41 mesoporous nanoparticle-based hybrid organic-inorganic material to detect ATP in a TRIS-HCl buffer (pH 7). To create the sensor, we synthesized MCM-41 silica nanoparticles and functionalized them with aminoanthracene and imidazolium-anthracene groups. The fluorescence responses of the optical sensor array were recorded and analyzed by using a pattern recognition protocol, specifically linear discriminant analysis, to distinguish between ATP, ADP, AMP, and potential interferents. Quantitative regression analysis of ATP in TRIS-HCl was performed using artificial neural networks, which yielded an acceptable error rate of 7.8%. The sensor array was also evaluated for discrimination of Parkinson's disease (PD) from healthy controls, based on pattern recognition of ATP-related analytes in saliva samples from 24 patients with PD and 23 healthy controls. The results showed that the MCM-41 mesoporous silica nanoparticle-based sensor array can discriminate PD by pattern recognition with 73.7% sensitivity and 83.3% specificity., The diagnostic part of this study is supported by the Ankara
University Scientific Research Projects Coordination Office
(TSA-2023-2648 and TSA-2025-3825). V.M.-C. acknowledges financial support from the Project CIDEGENT/2020/031
funded by the Generalitat Valenciana, Project ESGENT/2024/
001 funded by the Generalitat Valenciana, project PID2024-
157188OB-I00 funded by MICIU/AEI/10.13039/
501100011033 and FEDER A way to make Europe, project
PID2020-113256RA-I00 funded by MICIU/AEI/10.13039/
501100011033, and project CNS2023-144879 funded by
MICIU/AEI/10.13039/501100011033 and European Union
NextGenerationEU/PRTR. R.M.-M. acknowledges the European Union s Horizon EUROPE research and innovation
program under grant agreement no. 101093042, project
PID2024-155683OB-C41 funded by MICIU/AEI/10.13039/
501100011033 and FEDER A way to make Europe, project
PID2021-126304OB-C41 funded by MICIU/AEI/10.13039/
501100011033 and FEDER A way to make Europe, and
project PROMETEO CIPROM/2021/007 funded by Generalitat Valenciana. E.C. thanks the Instituto de Salud Carlos III
for founding the projects Miguel Servet 2023 CP23/00086 and
PI24_01239, both cofunded by the European Union.
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-113256RA-I00
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-126304OB-C41
,
European Commission / HE 101093042
,
Generalitat Valenciana CIDEGENT/2020/031
,
Generalitat Valenciana ESGENT/2024/001
,
Generalitat Valenciana CIPROM/2021/007
,
Instituto de Salud Carlos III CP23/00086
,
Instituto de Salud Carlos III PI24_01239
,
Ministerio de Ciencia PID2024-157188OB-I00
,
Innovación y Universidades CNS2023-144879
,
Agencia Estatal de Investigación PID2024-155683OB-C41